Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells

Bibliographic Details
Main Authors:	Sameehan Mahajani, Mathias Bähr, Sebastian Kügler
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=4;spage=692;epage=693;aulast=Mahajani

Similar Items

Midbrain dopaminergic neuron fate specification of pluripotent stem cells
by: Jaeger, Ines
Published: (2013)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
by: Xiling Yin, et al.
Published: (2021-06-01)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
by: Paula Chlebanowska, et al.
Published: (2020-08-01)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
by: Federica Bono, et al.
Published: (2017-01-01)

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
by: Douglas A. Grow, et al.
Published: (2016-09-01)

The effect of hypoxia on the differentiation of dopaminergic neurons from human pluripotent stem cells
by: Badger, J. L.
Published: (2013)

Zonisamide promotes survival of human induced pluripotent stem cell-derived dopaminergic neurons in the striatum of female rats
by: Miyawaki, Yoshifumi
Published: (2020)

Systemic administration of valproic acid and zonisamide promotes the survival and differentiation of induced pluripotent stem cell–derived dopaminergic neurons
by: Tatsuya eYoshikawa, et al.
Published: (2013-02-01)

Erratum: Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons.
by: Tatsuya eYoshikawa, et al.
Published: (2013-07-01)

Generation of human dopaminergic neurons from induced pluripotent stem cells to model Parkinson's disease
by: Sánchez Danés, Adriana, 1984-
Published: (2012)

Transmission Mechanism of Lewy Body-Like α-Synucleinopathies in Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells
by: Cheng Lin
Published: (2018-04-01)

Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease
by: Kikuchi, Tetsuhiro
Published: (2012)

Encapsulation of dopaminergic neurons derived from embryonic stem cells
by: Yamazoe, Hironori
Published: (2011)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders
by: James J. Fink, et al.
Published: (2018-04-01)

High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
by: Lily Sarrafha, et al.
Published: (2021-06-01)

Intrinsically Active and Pacemaker Neurons in Pluripotent Stem Cell-Derived Neuronal Populations
by: Sebastian Illes, et al.
Published: (2014-03-01)

Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
by: Aliasghar Karimi, et al.
Published: (2021-06-01)

Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell.
by: Yoo-Wook Kwon, et al.
Published: (2014-01-01)

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
by: Stefania Fedele, et al.
Published: (2017-07-01)

Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation
by: Daisuke Doi, et al.
Published: (2014-03-01)

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
by: Daisuke Doi, et al.
Published: (2020-07-01)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
by: Hayato Fukusumi, et al.
Published: (2021-02-01)

Striatal Transplantation of Human Dopaminergic Neurons Differentiated from Induced Pluripotent Stem Cells Derived from Umbilical Cord Blood Using Lentiviral Reprogramming
by: Anna Effenberg, et al.
Published: (2015-10-01)

Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology
by: Xiaojun Diao, et al.
Published: (2021-09-01)

Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications
by: Meghan Robinson, et al.
Published: (2015-01-01)

Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications
by: Meghan Robinson, et al.
Published: (2015-05-01)

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation
by: Kuo-Hsuan Chang, et al.
Published: (2021-09-01)

IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells
by: Daniela Lehnen, et al.
Published: (2017-10-01)

Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN‐4 downregulation
by: Serena Corti, et al.
Published: (2021-05-01)

Characterization of Induced Pluripotent Stem Cell-derived Human Serotonergic Neurons
by: Lining Cao, et al.
Published: (2017-05-01)

Neural Progenitor Cells Derived from Human Embryonic Stem Cells as an Origin of Dopaminergic Neurons
by: Parinya Noisa, et al.
Published: (2015-01-01)

In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation.
by: Bradley Watmuff, et al.
Published: (2012-01-01)

Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells
by: Kishi, Yo
Published: (2011)

Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells
by: James J. Fink, et al.
Published: (2017-04-01)

Using induced pluripotent stem cells derived neurons to model brain diseases
by: Cindy E McKinney
Published: (2017-01-01)

Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells
by: Jeong-Eun Yoo, et al.
Published: (2021-07-01)

Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells
by: Huan Yi, et al.
Published: (2018-01-01)

Cortical neurons derived from human pluripotent stem cells lacking FMRP display altered spontaneous firing patterns
by: Shreya Das Sharma, et al.
Published: (2020-06-01)

Generation of Dopaminergic Neurons from Human Embryonic Stem Cells
by: Vazin, Tandis
Published: (2008)